Fig. 4From: Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: a case report and literature reviewChanges in tumor burden under chemotherapy followed by radiotherapy and immunotherapy combination. RT: Radiotherapy, PDL1: programmed death ligand 1, CR: complete response, PR: partial responseBack to article page